Results 1 to 10 of about 12,086 (99)
Abandoning Eugenics and the QALY
INNOVATIONS in Pharmacy, 2021 Should decision making in health care, notably in respect of the allocation of resources between individuals and disease states, rest on notions of the burden of disease and denial of care as assessed by societal evaluations or on the extent to which the
Paul C Langley
doaj +1 more source
INNOVATIONS in Pharmacy, 2020 The QALY is an impossible construct; it defies common sense. It fails completely once we consider the axioms of fundamental measurement. Utilities as ordinal scales cannot be used to create QALYS. The QALY should never have been introduced to support the
Paul Langley
doaj +1 more source
Фармацевтичний журнал, 2023 Over the past decades, health policy makers have focused on early diagnosis to introduce targeted and innovative treatments. Early diagnosis of pulmonary arterial hypertension (PAH) is associated with improved long-term survival, so screening high-risk ...
I. S. Datsenko
doaj +1 more source
Фармацевтичний журнал, 2022 Pulmonary arterial hypertension (PAH) is a progressive and debilitating disease that causes the blood vessels in the lungs to thicken and narrow, forcing the heart to pump blood through the lungs at high pressure. In recent years, a significant number
I. S. Datsenko, A. V. Kabachna
doaj +1 more source
Евразийский Кардиологический Журнал, 2021 The study aims to estimate the MitraClip system’s cost-effectiveness compared with optimal medical therapy in adult patients with inoperable mitral regurgitation and assess its impact on the budget of the Russian Federation health system.Materials and ...
E. G. Fedina +3 more
doaj +1 more source
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review
Expert Review of Vaccines, 2023 Introduction Studies on economic evaluations of the 13-valent pneumococcal conjugate vaccine (PCV13) have been increasing over the last decade. No systematic reviews have synthesized the evidence of economic evaluations of the PCV13.
Yuanze Du +11 more
doaj +1 more source
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
Journal of Market Access & Health Policy, 2020 Objective: To provide recommendations for addressing previously identified key challenges in health economic evaluations of Gene Replacement Therapies (GRTs), including: 1) the assessment of clinical effectiveness; 2) the valuation of health outcomes; 3)
Samuel Aballéa +15 more
doaj +1 more source
Фармакоэкономика, 2019 The aim of the review was to analyze the availability of insulin therapy and the ways to improve it in countries with the largest number of patients with diabetes. It was also aimed to assess the medical, social and economic importance of insulin therapy
S. V. Ponomarenko
doaj +1 more source
Научно-практическая ревматология, 2010 Heavy economic expenses for treatment with genetic engineering biologicals (GEB) in patients with rheumatoid arthritis (RA) determine what strategies are most optimal in terms of both their clinical efficiency and economic constituent should be sought ...
Dmitry Vladimirovich Goryachev +2 more
doaj +1 more source
QALY: Quality Adjusted Life Year
Medicine Science, 2012 Nufusun yaslanmasi ve yaslilik donemi hastaliklar ile kronik hastaliklarin one cikmasi verilen saglik hizmetlerinin sadece saglik duzeyi uzerine degil yasam kalitesine etkisinin de onemli bir cikti olarak degerlendirilmesini getirmistir.
Selale Sahin, Selime Toprak, Erdinc Unal
doaj +1 more source